NEW YORK (GenomeWeb) – Diagnostics firm Novacyt today reported its sales for the first half of the year jumped 40 percent year over year. The results include contributions from its acquisition of Primerdesign in May 2016.

The company posted €7 million ($8.1 million) in sales for the first six months of 2017, up from €5 million in H1 2016. At constant exchange rates, Novacyt's sales were up 53 percent year over year, it said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.